In order to better understand how Angiotensin II type 1 receptor-associated protein (ATRAP) contributes to breast cancer progression, we first examined publicly available expression profiles in The Cancer Genome Atlas (TCGA) (https://tcga-data.nci.nih.gov/). Here, AGTRAP is linked to breast carcinoma.